Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
GSK's RSV, Shingles vaccines show on-par immune response in joint trial
(Reuters) -British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot together generated the same immune response in a late-stage trial as separate adminstration of the vaccines.
GSK Sees Positive Results in Trial of Combination RSV, Shingles Vaccine
GSK recorded positive topline data in a late stage trial of its respiratory syncytial virus vaccine combined with a shingles vaccine in treating adults 50 years and older.
GSK Reports Positive Data From Co-administration Of RSV And Shingles Vaccines
GSK plc (GSK, GSK.L) announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the
GSK Builds Combo Case for RSV, Shingles Shots With Phase III Data
If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients and potentially bolster GSK’s faltering sales for both vaccines.
GSK's Respiratory Syncytial Virus Vaccine Given Together With Shingles Shot Shows Non-Inferior Immune Response In Older Adults
GSK released data from a Phase 3 trial evaluating the co-administration of Arexvy and Shingrix vaccines in adults 50+. The study showed a non-inferior immune response and good safety profiles. The results will support regulatory submissions to the FDA and EMA.
GSK pursues co-administration of RSV and shingles vaccines
GSK has revised its annual vaccine sales forecast following new guidance on RSV from the CDC. But new evidence offers new hope.
GSK touts co-administration data for RSV, shingles vaccines as narrowed CDC guidance threatens sales
In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses compared with separate administration of the vaccines.
Good signs for co administration of GSK’s RSV and shingles vaccines
UK drugmaker GSK presented positive Phase III trial data at the European Geriatric Medicine Society Congress. The trial showed that co-administering Arexvy (RSV vaccine) and Shingrix (shingles vaccine) in adults 50+ produced a non-inferior immune response and was well tolerated.
GSK Reports Findings on Coadministered RSV and Shingles Vaccines
Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.
GSK's RSV vaccine meets main goal when co-administered with shingles shot
British drugmaker GSK said on Wednesday its respiratory syncytial virus (RSV) vaccine, when given together with its shingles shot, met the main goal of a late-stage trial in adults over 50 years of age.
GSK posts late-stage trial win for co-administered RSV and shingles vaccines
GSK (GSK) reached the main goal in a Phase 3 trial for its RSV shot, Arexvy co--administered with Shingles vaccine Shingrix. Read more here.
Gazeta.pl on MSN
1d
A Vaccine Against an Infectious Disease Protects Against Dementia? "Intriguing"
The latest research suggests that the recombinant shingles vaccine may offer additional benefits. It appears to reduce the ...
1d
5 Vaccines You Need After 50: These Shots Can Help Protect Against Illnesses as You Get Older
Closer takes a look at five vaccines you should get after you turn 50 to help protect against illness. Shingles: “The first ...
27d
Flu, RSV and shingles could be problematic for some older adults
Respiratory syncytial virus (RSV) is a common virus that usually causes mild, cold-like symptoms. You may have heard of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Secret Service admits failure
Kentucky judge fatally shot
Whooping cough cases spike
Boy kills bear, saves father
Russia threatens retaliation
Secret Service probing post
Body found in SUV
Feds subpoena Schaeffer
$230 million crypto theft
Remains ID'd as KY shooter
Pandas leaving for China
House repeals emission rules
WI high court to decide
Hiker injured in bear attack
Hand count approved in GA
1st rabies outbreak in seals
Sues pharmacy middlemen
Bill to boost security OK'd
Hold campaign event in MI
Baby powder recalled
FDA approves flu vaccine
144K+ Mavericks recalled
Top Hezbollah leader killed?
In-person voting begins
Raises settlement offer
MS sheriff's office probe
Recalling 449K+ vehicles
Collapse hazard recall
PGA welcomes LIV players
Vows to remain in race
Stein's ballot bid rejected
Disney to stop using Slack
$3B for battery projects
Related topics
GSK
RSV
GlaxoSmithKline
Centers for Disease Control and Prevention
Rous sarcoma virus
Feedback